MAROPITANT CITRATE

Solicitation SPE2DP-26-T-4934 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Maropitant Citrate, a veterinary drug regulated by the FDA. The requirement consists of 3 packages of 160mg tablets, with each package containing a blister pack of 4 tablets per perforated sheet. The product must be stored at a controlled room temperature of 20-25 C, with allowable excursions between 15-30 C, and has a non-extendable shelf life of 36 months. Delivery is set for 88 days after order, with an original required delivery date of September 8, 2026. The terms are FOB Destination, with both inspection and acceptance occurring at the destination in Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and DLA packaging requirements, while marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various DFARS and FAR clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.